Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.

Abstract

PURPOSE Nasopharyngeal carcinoma (NPC) has been proven as an Epstein-Barr virus (EBV)-associated cancer. Serum anti-EBV antibodies and plasma EBV DNA have been investigated as surrogate markers for NPC. A comparison of the prognostic impacts of both assays has never been reported. METHODS AND MATERIALS Paired serum and plasma samples from 114 previously… (More)

Topics

Cite this paper

@article{Twu2007ComparisonOT, title={Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.}, author={Chih-Wen Twu and Wen-yi Wang and Wen-Miin Liang and Jian-Sheng Jan and Rong-San Jiang and Jeffrey Yung-Chuan Chao and Ying-Tai Jin and Jin-Ching Lin}, journal={International journal of radiation oncology, biology, physics}, year={2007}, volume={67 1}, pages={130-7} }